Skip to main content

Alfons Macaya Ruíz

Institutions of which they are part

Head of group
Pediatric Neurology
Vall Hebron Institut de Recerca

Alfons Macaya Ruíz

Institutions of which they are part

Head of group
Pediatric Neurology
Vall Hebron Institut de Recerca

Projects

Aproximación clínico-genética a la etiopatogénica del trastorno del espectro autista (TEA) y del trastorno por déficit de atención con hiperactividad (TDHA): Estudio en una muestra de niños y adultos con TDAH

IP: Miquel Casas Brugué
Collaborators: Xavier Agustin Gastaminza Pérez, Alfons Macaya Ruíz, José Antonio Ramos Quiroga
Funding agency: Instituto de Salud Carlos III
Funding: 66700
Reference: PI040524
Duration: 01/01/2005 - 28/11/2007

Avaluació de gens de susceptibilitat a la migranya mitjançant estudis d'associació a variants polimòrfiques tipus SNP

IP: Alfons Macaya Ruíz
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13200
Reference: PRED/IR-HUVH/30/2004
Duration: 01/01/2005 - 31/12/2008

Biología, clínica y terapia de la ataxias cerebelosas.

IP: Alfons Macaya Ruíz
Collaborators: Josep Gamez Carbonell
Funding agency: Instituto de Salud Carlos III
Funding: 90000
Reference: G03/056
Duration: 01/01/2003 - 31/12/2005

Evaluación de genes de susceptibilidad a migraña mediante estudios de asociación a variantes polimórficas tipo SNP y análisis de ligamento genético en sujetos y familias con migraña.

IP: Alfons Macaya Ruíz
Collaborators: Mireia Del Toro Riera
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 92000
Reference: SAF2003-04704
Duration: 15/12/2003 - 14/12/2006

Ministerio de Ciencia

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Carlos  González Cruz

Carlos González Cruz

Predoctoral researcher
Biomedical Research in Melanoma
Read more
Jacob Thomas Herbert

Jacob Thomas Herbert

Digital Transformation Directorate
Read more
Cristina Losada Gimenez

Cristina Losada Gimenez

Research technician
Stroke research
Read more
Braulio Andrés Ortega Quesada

Braulio Andrés Ortega Quesada

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.